Home268600 • KOSDAQ
add
Cellivery Therapeutics Inc
Previous close
₩6,680.00
Year range
₩6,680.00 - ₩6,680.00
Market cap
244.25B KRW
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.90B | -55.35% |
Operating expense | 777.77M | -67.09% |
Net income | -1.31B | 71.61% |
Net profit margin | -68.74 | 36.40% |
Earnings per share | — | — |
EBITDA | -692.54M | 65.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 133.78M | -70.08% |
Total assets | 20.77B | -36.39% |
Total liabilities | 43.16B | -24.85% |
Total equity | -22.40B | — |
Shares outstanding | 37.18M | — |
Price to book | -12.27 | — |
Return on assets | -15.17% | — |
Return on capital | -23.87% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.31B | 71.61% |
Cash from operations | -325.12M | 84.23% |
Cash from investing | 97.74M | -72.21% |
Cash from financing | 296.34M | -37.99% |
Net change in cash | 68.95M | 105.53% |
Free cash flow | 1.35B | 110.83% |
About
CEO
Founded
2014
Website
Employees
4
